The Chinese biopharmaceutical industry has reportedly entered an innovation phase (2.0), focusing on commercialising its products, which might lead to surpassing the US in pharmaceutical market leader...

Recent analyses have shown that China's pharmaceutical output has matched the United States, with new drug discoveries tripling from about 30 in 2013 to over 400 by a decade later. This achievement ma...

Chinese pharmaceutical companies have recently engaged in multiple out-licensing agreements with international partners, highlighting China’s increasing significance as a source for innovative medicin...

The human genome has been imaged in 4D, showing how genes interact, fold and reposition themselves over time. This development builds on the original Human Genome Project from the early 2000s and prom...

HC Wainwright has reaffirmed its buy rating on Rani Therapeutics (NASDAQ: RANI) and set a price target of $11.00 per share, according to a report released on Friday....

On Monday, Evogene Ltd.'s (NASDAQ: EVGN) stock price dropped below its 50-day moving average of $1.12, trading as low as this threshold. The company's shares closed at the same value. Analyst Weiss ma...

In the third quarter, Diversified Trust Co increased its stake in Bristol Myers Squibb Company by 56%, acquiring an additional 36,288 shares. The fund currently holds 101,051 shares of the biopharmace...

JPMorgan Chase & Co. raised its price target on Xenon Pharmaceuticals shares from $60.00 to $62.00, maintaining an overweight rating for the biopharmaceutical company....

HC Wainwright maintained a 'Buy' rating and set a $20.00 price target for Enanta Pharmaceuticals' stock. Other financial institutions are also beginning to cover or reassess their stance on the compan...

Comprehensive Money Management Services LLC substantially decreased its holdings of the Global X Genomics & Biotech ETF (NYSE: GNOM) by selling 15,264 shares during Q3, reducing their position to 5,24...

Osaic Holdings Inc. increased its holdings of Exelixis, Inc. (NASDAQ:EXEL) by 151.9% in the second quarter after purchasing an additional 41,167 shares, bringing its total to 68,276 shares....

Barrington Research has maintained its 'outperform' rating on Anika Therapeutics (NASDAQ: ANIK) stock, setting a price target of $16 per share. This announcement follows other recent evaluations from ...

Ellsworth Advisors LLC acquired 10,006 shares of Corcept Therapeutics Incorporated stock during the third quarter, with a total investment value of approximately $769,000. This information was disclos...

Citigroup initiated coverage on Vor Biopharma's shares with a 'buy' rating and a $50.00 price target, according to Marketbeat.com. Baird R W also recently raised its opinion on the stock....

On Thursday, Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) experienced a new high in its stock price within the last year. The peak trading value was $186.25, while it closed at $175.81, w...

Permanent Capital Management LP acquired 147,769 shares of Aura Biosciences during the third quarter, with a total investment value of approximately $913,000....

Connective Portfolio Management LLC purchased 24,500 shares of Legend Biotech Corporation Sponsored ADR (NASDAQ: LEGN) during the third quarter. The total investment is valued at around $805,000....

MBX Biosciences stock surged to reach a new one-year high of $35.55 on Tuesday, closing at $34.80 and seeing a trading volume of 989,369 shares. The previous close had been at $30.42....